SECURITIES AND EXCHANGE COMMISSION |
|
|
|
Washington, D.C. 20549 |
|
_______________ |
|
|
|
SCHEDULE 13D |
|
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a) |
|
Under the Securities Exchange Act of 1934 |
(Amendment No. ) |
|
Mercury Systems, Inc.
|
(Name of Issuer) |
|
Common Stock, par value $0.01 per share
|
(Title of Class of Securities) |
|
589378108
|
(CUSIP Number) |
|
Eleazer Klein, Esq.
Marc Weingarten, Esq.
|
919 Third Avenue |
New York, New York 10022 |
(212) 756-2000
|
(Name, Address and Telephone Number of Person |
Authorized to Receive Notices and Communications) |
|
December 13, 2021
|
(Date of Event which Requires |
Filing of this Schedule) |
If
the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or
13d-1(g), check the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits.
See Rule 13d-7 for other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 17 Pages)
--------------------------
The
information required on the remainder of this cover page shall not
be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
2
of 17 Pages |
1 |
NAME OF
REPORTING PERSON
JANA PARTNERS LLC
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP |
(a) ¨
(b) ¨
|
3 |
SEC USE ONLY |
4 |
SOURCE
OF FUNDS
AF
|
5 |
CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
7 |
SOLE
VOTING POWER
3,731,962 Shares (including options to purchase 173,300 Shares)
|
8 |
SHARED
VOTING POWER
0
|
9 |
SOLE
DISPOSITIVE POWER
3,731,962 Shares (including options to purchase 173,300 Shares)
|
10 |
SHARED
DISPOSITIVE POWER
0
|
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
3,731,962 Shares (including options to purchase 173,300 Shares)
|
12 |
CHECK IF THE AGGREGATE AMOUNT IN ROW
(11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)
6.6%
|
14 |
TYPE OF
REPORTING PERSON
IA
|
|
|
|
|
|
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
3
of 17 Pages |
1 |
NAME OF
REPORTING PERSON
JIM ALBAUGH
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP |
(a) ¨
(b) ¨
|
3 |
SEC USE ONLY |
4 |
SOURCE
OF FUNDS
PF
|
5 |
CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
7 |
SOLE
VOTING POWER
15,000 Shares
|
8 |
SHARED
VOTING POWER
0
|
9 |
SOLE
DISPOSITIVE POWER
15,000 Shares
|
10 |
SHARED
DISPOSITIVE POWER
0
|
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
15,000 Shares
|
12 |
CHECK IF THE AGGREGATE AMOUNT IN ROW
(11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)
Less than 0.1%
|
14 |
TYPE OF
REPORTING PERSON
IN
|
|
|
|
|
|
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
4
of 17 Pages |
1 |
NAME OF
REPORTING PERSON
BILL BALLHAUS
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP |
(a) ¨
(b) ¨
|
3 |
SEC USE ONLY |
4 |
SOURCE
OF FUNDS
PF
|
5 |
CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
7 |
SOLE
VOTING POWER
5,065 Shares
|
8 |
SHARED
VOTING POWER
0
|
9 |
SOLE
DISPOSITIVE POWER
5,065 Shares
|
10 |
SHARED
DISPOSITIVE POWER
0
|
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
5,065 Shares
|
12 |
CHECK IF THE AGGREGATE AMOUNT IN ROW
(11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)
Less than 0.1%
|
14 |
TYPE OF
REPORTING PERSON
IN
|
|
|
|
|
|
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
5
of 17 Pages |
1 |
NAME OF
REPORTING PERSON
CAROL LOWE
|
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP |
(a) ¨
(b) ¨
|
3 |
SEC USE ONLY |
4 |
SOURCE
OF FUNDS
PF
|
5 |
CHECK BOX IF DISCLOSURE OF LEGAL
PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
7 |
SOLE
VOTING POWER
1,205 Shares
|
8 |
SHARED
VOTING POWER
0
|
9 |
SOLE
DISPOSITIVE POWER
1,205 Shares
|
10 |
SHARED
DISPOSITIVE POWER
0
|
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
1,205 Shares
|
12 |
CHECK IF THE AGGREGATE AMOUNT IN ROW
(11) EXCLUDES CERTAIN SHARES |
¨ |
13 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11) (see Item 5)
Less than 0.1%
|
14 |
TYPE OF
REPORTING PERSON
IN
|
|
|
|
|
|
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
6
of 17 Pages |
Item 1. |
SECURITY AND ISSUER. |
This statement on Schedule 13D relates to the shares
(“Shares”) of common stock, par value $0.01 per share, of
Mercury Systems, Inc., a Massachusetts corporation (the
“Issuer”). The principal executive office of the Issuer is
located at 50 Minuteman Road, Andover, Massachusetts 01810.
Item 2. |
IDENTITY AND BACKGROUND. |
(a) This statement is filed by (i) JANA Partners LLC, a Delaware
limited liability company (“JANA”), (ii) Jim Albaugh
(“Mr. Albaugh”), (iii) Bill Ballhaus (“Mr. Ballhaus”)
and (iv) Carol Lowe (“Ms. Lowe” and together with Mr.
Albaugh and Mr. Ballhaus, the “Nominees”, the Nominees
together with JANA, the “Reporting Persons”). JANA is a
private money management firm which holds Shares of the Issuer in
various accounts under its management and control. The principal
owner of JANA is Barry Rosenstein (the “Principal”).
(b) The principal business address of JANA and the Principal is
1330 Avenue of the Americas, 31st Floor, New York, New York 10019.
The principal business address of each of the Nominees is c/o JANA
Partners LLC, 1330 Avenue of the Americas, 31st Floor, New York,
New York 10019.
(c) The principal business of JANA and the Principal is investing
for accounts under their management. The principal business of Mr.
Albaugh is serving as Senior Advisor to Industrial Development
Funding, LLC after previously serving as a senior executive at The
Boeing Company. The principal business of Mr. Ballhaus is serving
as Founder and Chairman of MilestoneRoad Holdings, LLC after
previously serving as the Chairman, Chief Executive Officer and
President of Blackboard Inc. and Chief Executive Officer of SRA
International. The principal business of Ms. Lowe is serving as
Founder and Chief Executive Officer of Act III Advisory, LLC after
previously serving as the Chief Financial Officer of FLIR Systems
Inc.
(d) None of the Reporting Persons nor the Principal has, during the
last five years, been convicted in a criminal proceeding (excluding
traffic violations or similar misdemeanors).
(e) None of the Reporting Persons nor the Principal has, during the
last five years, been a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result of
such proceeding was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
(f) JANA is a limited liability company organized in Delaware. Each
of the Principal and the Nominees is a citizen of the United States
of America.
Item 3. |
SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. |
The 3,731,962 Shares (including options to purchase 173,300 Shares)
reported herein by JANA were acquired at an aggregate purchase
price of approximately $181.1 million. Such Shares were acquired
with investment funds in accounts managed by JANA and margin
borrowings described in the following sentence. Such Shares are
held by the investment funds managed by JANA in commingled margin
accounts, which may extend margin credit to JANA from time to time,
subject to applicable federal margin regulations, stock exchange
rules and credit policies. In such instances, the positions held in
the margin accounts are pledged as collateral security for the
repayment of debit balances in the account. The margin accounts
bear interest at a rate based upon the broker’s call rate from time
to time in effect. Because other securities are held in the margin
accounts, it is not possible to determine the amounts, if any, of
margin used to purchase the Shares reported herein.
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
7
of 17 Pages |
Mr. Albaugh used a total of approximately $736,000 in the aggregate
to acquire the 15,000 Shares reported herein as beneficially owned
by him.
Mr. Ballhaus used a total of approximately $251,000 in the
aggregate to acquire the 5,065 Shares reported herein as
beneficially owned by him.
Ms. Lowe used a total of approximately $60,000 in the aggregate to
acquire the 1,205 Shares reported herein as beneficially owned by
her.
Item 4. |
PURPOSE OF TRANSACTION. |
The Reporting Persons acquired the Shares because they believe the
Shares are undervalued and represent an attractive investment
opportunity. JANA, with the assistance of the other Reporting
Persons, intends to have discussions with the Issuer’s
board of directors (the “Board”) and
management regarding maximizing value for shareholders
including evaluating strategic alternatives including a sale
of the Issuer, operations, capital allocation, corporate
governance, board composition, and compensation practices.
The Reporting Persons expect to have discussions with stockholders
and other interested parties relating to all such
matters.
The Reporting Persons may also take other steps to increase
stockholder value as well as pursue other plans or proposals that
relate to or would result in any of the matters set forth in
subparagraphs (a)-(j) of Item 4 of Schedule 13D, excluding (i)
acquiring a control stake in the Issuer’s Shares, or grouping with
any other party or parties to do so, (ii) engaging in an
extraordinary transaction, such as a merger, with the Issuer, or
acquiring a material amount of the Issuer’s assets, or grouping
with any other party or parties to do either, or (iii) seeking to
exert negative control over the important corporate actions of the
Issuer, or grouping with any other party or parties to do so,
although the Reporting Persons may seek to influence such actions
through customary means including presenting their views for
consideration to the Issuer, stockholders and other interested
parties, privately or publicly, and, if necessary, through the
exercise of their stockholder rights including the right to propose
new directors for the Board.
Depending on various factors including, without limitation, the
Issuer’s financial position and strategic direction, the outcome of
the discussions and actions referenced above, actions taken by the
Board, price levels of the Shares, other investment opportunities
available to the Reporting Persons, conditions in the securities
market and general economic and industry conditions, the Reporting
Persons may in the future take such actions with respect to their
investment position in the Issuer as they deem appropriate
including, without limitation, purchasing additional Shares or
selling some or all of their Shares, and/or engaging in short
selling of or hedging or similar transactions with respect to the
Shares.
Item 5. |
INTEREST IN SECURITIES OF THE COMPANY. |
(a) The aggregate percentage of Shares reported to be beneficially
owned by the Reporting Persons is based upon 56,645,864 Shares
outstanding as of October 31, 2021, as reported in the Issuer’s
Quarterly Report on Form 10-Q for the quarterly period ended
October 1, 2021 filed with the Securities and Exchange Commission
on November 9, 2021.
As of the close of business on the date hereof, JANA may be deemed
to beneficially own 3,731,962 Shares (including options to purchase
173,300 Shares), representing approximately 6.6% of the Shares
outstanding.
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
8
of 17 Pages |
As of the close of business on the date hereof, Mr. Albaugh may be
deemed to beneficially own 15,000 Shares, representing less than
0.1% of the Shares outstanding.
As of the close of business on the date hereof, Mr. Ballhaus may be
deemed to beneficially own 5,065 Shares, representing less than
0.1% of the Shares outstanding.
As of the close of business on the date hereof, Ms. Lowe may be
deemed to beneficially own 1,205 Shares, representing less than
0.1% of the Shares outstanding.
By virtue of the Nomination Agreements (as defined in
Item 6 below), JANA, Mr. Albaugh, Mr. Ballhaus and Ms. Lowe may be
deemed to have formed a “group” within the meaning of Section
13(d)(3) of the Exchange Act and may be deemed to beneficially own
an aggregate of 3,753,232 Shares (including options to purchase
173,300 Shares), representing approximately 6.6% of the outstanding
Shares. Mr. Albaugh expressly disclaims beneficial ownership of the
Shares beneficially owned by JANA and the other Nominees. Mr.
Ballhaus expressly disclaims beneficial ownership of the Shares
beneficially owned by JANA and the other Nominees. Ms. Lowe
expressly disclaims beneficial ownership of the Shares beneficially
owned by JANA and the other Nominees. JANA expressly disclaims
beneficial ownership of the Shares beneficially owned by each of
the Nominees.
(b) JANA has sole voting and dispositive power over the 3,731,962
Shares (including options to purchase 173,300 Shares), which power
is exercised by the Principal. Mr. Albaugh has sole voting and
dispositive power over the 15,000 Shares beneficially owned by him.
Mr. Ballhaus has sole voting and dispositive power over the 5,065
Shares beneficially owned by him. Ms. Lowe has sole voting and
dispositive power over the 1,205 Shares beneficially owned by
her.
(c) Information concerning transactions in the Shares effected by
the Reporting Persons during the past sixty days is set forth in
Exhibit A hereto and is incorporated herein by reference.
All of the transactions in Shares listed hereto were effected in
the open market through various brokerage entities.
(d) No person (other than the Reporting Persons) is known to have
the right to receive or the power to direct the receipt of
dividends from, or the proceeds from the sale of, the Shares.
(e) Not applicable.
Item 6. |
CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER. |
Each of the Nominees has entered into a nomination agreement
(collectively, the “Nominee Agreement”) with an affiliate of
JANA substantially in the form attached as Exhibit B to
this Schedule 13D whereby the Nominees agreed to become members of
a slate of nominees and stand for election as directors of the
Issuer in connection with a proxy solicitation which may be
conducted in respect of the Issuer’s upcoming annual meeting of
stockholders (the “Annual Meeting”). Pursuant to the Nominee
Agreement, a JANA affiliate has agreed to pay the costs of
soliciting proxies in connection with the Annual Meeting, and to
defend and indemnify the Nominees against, and with respect to, any
losses that may be incurred by the Nominees in the event they
become a party to litigation based on their nomination as
candidates for election to the Board and the solicitation of
proxies in support of their election. Each of the Nominees received
compensation under the Nominee Agreement in the amount of $60,000,
and will receive an additional $128,700 in the event of his or her
appointment or election. Each of the Nominees agreed to hold Shares
with a market-value equal to $188,700 (adjusted for taxes) as of
the date of his or her election or appointment (subject to certain
exceptions), until the later of when he or she is no longer a
director of the
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
9
of 17 Pages |
Issuer and three years (subject to certain exceptions). The
foregoing summary of the Nominee Agreement is not complete and is
qualified in its entirety by reference to the full text of the form
of Nominee Agreement, a copy of which is attached
as Exhibit B and is incorporated by reference
herein.
JANA beneficially owns 1,733 call options for 173,300 Shares with a
strike price of $36 and which expire on February 18, 2022.
Except as otherwise set forth herein, and the joint filing
agreement attached hereto as Exhibit C, the Reporting
Persons have no contracts, arrangements, understandings or
relationships with any person with respect to the securities of the
Issuer.
Item 7. |
MATERIAL TO BE FILED AS EXHIBITS. |
Exhibit A: |
Transactions in the Shares of the Issuer During the Last 60
Days |
Exhibit B: |
Form of Nominee Agreement |
Exhibit C: |
Joint Filing Agreement, dated December 23, 2021 |
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
10
of 17 Pages |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
Dated: December 23, 2021
|
JANA PARTNERS LLC |
|
|
|
|
|
By: |
/s/ Jennifer Fanjiang |
|
Name: |
Jennifer Fanjiang |
|
Title: |
Partner, Chief Legal Officer
and Chief Compliance Officer |
|
|
|
|
|
|
|
|
/s/ Jim Albaugh |
|
|
JIM ALBAUGH |
|
|
|
|
|
|
|
|
|
|
|
/s/ Bill Ballhaus |
|
|
BILL BALLHAUS |
|
|
|
|
|
|
|
|
|
|
|
/s/ Carol Lowe |
|
|
CAROL LOWE |
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
11
of 17 Pages |
EXHIBIT A
Transactions in the Shares of the Issuer by JANA and by each of
the Nominees During the Last Sixty (60) Days
The following tables set forth all transactions in the Shares
effected in the past sixty days by the Reporting Persons. Except as
noted below, all such transactions were effected in the open market
through brokers and the price per share includes commissions. Where
a price range is provided in the column Price Range ($), the
price reported in that row’s column Price Per Share ($) is a
weighted average price. These Shares were purchased in multiple
transactions at prices between the price ranges indicated in the
column Price Range ($). The Reporting Persons will undertake to
provide to the staff of the SEC, upon request, full information
regarding the number of Shares sold at each separate price.
JANA
Trade Date |
Shares Purchased (Sold) |
Price Per Share ($) |
Price Range ($) |
10/25/2021 |
12,800 |
53.23 |
|
11/3/2021 |
13,245 |
49.95 |
|
11/9/2021 |
800 |
51.24 |
|
11/10/2021 |
65,118 |
52.37 |
52.35-52.51 |
11/11/2021 |
1,000 |
50.52 |
|
11/15/2021 |
139,272 |
52.01 |
51.95-52.22 |
11/16/2021 |
87,428 |
52.26 |
52.24-52.31 |
11/17/2021 |
138,702 |
51.65 |
51.58-51.75 |
11/18/2021 |
193,265 |
50.18 |
49.97-50.24 |
11/19/2021 |
253,503 |
49.65 |
49.60-49.66 |
11/22/2021 |
64,607 |
50.01 |
49.33-50.45 |
11/23/2021 |
91,188 |
49.50 |
49.33-49.53 |
11/24/2021 |
62,000 |
49.84 |
|
11/26/2021 |
153,000 |
48.41 |
48.37-48.42 |
11/29/2021 |
190,026 |
48.78 |
48.67-48.80 |
11/30/2021 |
206,885 |
49.05 |
48.89-49.20 |
12/1/2021 |
71,849 |
49.35 |
|
12/6/2021 |
91,153 |
48.08 |
47.81-48.40 |
12/9/2021 |
50,000 |
46.96 |
|
12/13/2021 |
171,561 |
47.76 |
47.48-48.07 |
12/14/2021 |
94,406 |
49.23 |
48.97-49.41 |
12/15/2021 |
120,532 |
49.84 |
49.16-50.59 |
12/16/2021 |
217,300 |
50.49 |
50.46-50.88 |
12/17/2021 |
44,527 |
50.74 |
50.73-50.76 |
12/20/2021 |
44,312 |
49.71 |
49.62-49.74 |
12/21/2021 |
46,900 |
51.24 |
|
12/22/2021 |
21,800 |
51.36 |
50.82-51.36 |
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
12
of 17 Pages |
Mr. Albaugh
Trade Date |
Shares Purchased (Sold) |
Price Per Share ($) |
Price Range ($) |
|
|
|
|
12/13/2021 |
5,000 |
47.61 |
|
12/15/2021 |
2,496 |
49.00 |
|
12/16/2021 |
2,504 |
50.63 |
|
12/17/2021 |
2,000 |
50.81 |
|
12/20/2021 |
3,000 |
48.98 |
|
Mr. Ballhaus
Trade Date |
Shares Purchased (Sold) |
Price Per Share ($) |
Price Range ($) |
|
|
|
|
11/3/2021 |
1,000 |
49.75 |
|
11/22/2021 |
1,000 |
49.53 |
|
11/26/2021 |
1,000 |
48.62 |
|
12/3/2021 |
1,064.96 |
46.95 |
|
Ms. Lowe
Trade Date |
Shares Purchased (Sold) |
Price Per Share ($) |
Price Range ($) |
|
|
|
|
12/17/2021 |
1,205 |
49.77 |
|
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
13
of 17 Pages |
Exhibit B
Form of Nominee Agreement
This Nomination Agreement (the “Agreement”) is by and between JANA
Special Situations Management, LP (“JANA,” “we” or
“us”) and [NAME] (“you”).
You agree that you are willing, should we so elect, to become a
member of a slate of nominees (the “Slate”) of a JANA
affiliate (the “Nominating Party”) which nominees shall stand for
election as directors of Mercury Systems, Inc. (“MRCY”) in
connection with a proxy solicitation (the “Proxy
Solicitation”) which may be conducted in respect of the 2022
annual meeting of stockholders of MRCY (including any adjournment
or postponement thereof or any special meeting held in lieu
thereof, the “Annual Meeting”) or appointment or election by
other means. You further agree to serve as a director of MRCY if so
elected or appointed. JANA agrees on behalf of the Nominating Party
to pay the costs of the Proxy Solicitation. JANA also agrees on
behalf of the Nominating Party to pay you, (i) $60,000 within three
(3) business days of the date hereof and (ii) in the event that you
are elected or appointed as a director of MRCY, $128,700 within
three (3) business days of such election or appointment, provided
that to the extent that you do not own on the date of such election
or appointment shares of common stock of MRCY (“Shares”) with a
market value (based on the closing price of the Shares on the date
of such election or appointment) equal to at least the estimated
after-tax proceeds of $188,700 (assuming a combined federal, state
and city tax rate of 45%, rounded to the nearest whole dollar), you
agree to purchase an amount of Shares with a market value (based on
the closing price of the Shares on the date of such election or
appointment) equivalent to or greater than such after-tax amount
within twenty (20) business days of receipt of such payment (or
such longer period as may be required to comply with any legal or
regulatory requirements or policies of the Board). You agree to
hold any Shares purchased by you in accordance with this paragraph
(and any other Shares purchased by you which were taken into
account in satisfying the share ownership obligation set forth in
the prior sentence) until at least the later of (A) the first date
as of which you are no longer a director of MRCY and (B) three (3)
years from the date of such appointment or election (or if earlier,
the date of the consummation of any merger or sale of MRCY which
has been approved if applicable by the Board and the holders of the
requisite number of Shares).
JANA agrees on behalf of the Nominating Party that JANA will
defend, indemnify and hold you harmless from and against any and
all losses, claims, damages, penalties, judgments, awards,
settlements, liabilities, costs, expenses and disbursements
(including, without limitation, reasonable attorneys’ fees, costs,
expenses and disbursements) incurred by you in the event that you
become a party, or are threatened to be made a party, to any civil,
criminal, administrative or arbitrative action, suit or proceeding,
and any appeal thereof, (i) relating to your role as a nominee for
director of MRCY on the Slate, or (ii) otherwise arising from or in
connection with or relating to the Proxy Solicitation. Your right
of indemnification hereunder shall continue after the Annual
Meeting has taken place but only for events that occurred prior to
the Annual Meeting and subsequent to the date hereof. Anything to
the contrary herein notwithstanding, JANA is not indemnifying you
for any action taken by you or on your behalf that occurs prior to
the date hereof or subsequent to the conclusion of the Proxy
Solicitation or such earlier time as you are no longer a nominee on
the Slate or for any actions taken by you as a director of MRCY, if
you are elected. Nothing herein shall be construed to provide you
with indemnification (i) if you are found to have engaged in a
violation of any provision of state or federal law in connection
with the Proxy Solicitation, unless you demonstrate that your
action was taken in good faith and in a manner you reasonably
believed to be in or not opposed to the best interests of electing
the Slate; (ii) if you acted in a manner that constitutes gross
negligence or willful misconduct; or (iii) if you provided false or
misleading information, or omitted material information, in the
JANA Questionnaire (as defined below) or otherwise in connection
with the
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
14
of 17 Pages |
Proxy Solicitation. You shall promptly notify JANA in writing in
the event of any third-party claims actually made against you or
known by you to be threatened if you intend to seek indemnification
hereunder in respect of such claims; provided, however, that any
failure by you to notify JANA of any claim shall not relieve JANA
of any liability which JANA may have to you except only to the
extent that any such delay in giving or failure to give notice as
required materially prejudices the defense of such claim. In
addition, upon your delivery of notice with respect to any such
claim, JANA shall promptly assume control of the defense of such
claim with counsel chosen by JANA and shall advise you of the
progress thereof and all significant actions proposed. JANA shall
not be responsible for any settlement of any claim against you
covered by this indemnity without its prior written consent.
However, JANA may not enter into any settlement of any such claim
without your consent unless such settlement includes (i) no
admission of liability or guilt by you, and (ii) an unconditional
release of you from any and all liability or obligation in respect
of such claim. If you are required to enforce the obligations of
JANA in this Agreement in a court of competent jurisdiction, or to
recover damages for breach of this Agreement, JANA will pay on your
behalf, in advance, any and all expenses (including, without
limitation, reasonable attorneys’ fees, costs, expenses and
disbursements) actually and reasonably incurred by you in such
action, regardless of whether you are ultimately determined to be
entitled to such indemnification or advancement of expenses.
You understand that it may be difficult, if not impossible, to
replace a nominee who, such as yourself, has agreed to serve on the
Slate and, if elected, as a director of MRCY if such nominee later
changes his mind and determines not to serve on the Slate or, if
elected, as a director of MRCY. Accordingly, JANA is relying upon
your agreement to serve on the Slate and, if elected, as a director
of MRCY. In that regard, you may be supplied with a questionnaire
(the “JANA Questionnaire”) in which you will provide JANA
with information necessary for the Nominating Party to make
appropriate disclosure to MRCY and to use in creating the proxy
solicitation materials to be sent to stockholders of MRCY and filed
with the Securities and Exchange Commission in connection with the
Proxy Solicitation. In the event that the Nominating Party files
with the Securities and Exchange Commission any proxy solicitation
materials, the Nominating Party agrees to provide you with an
opportunity to comment on those sections of the proxy solicitation
materials that relate to any personal information concerning you
contained in such materials.
You agree that (i) upon request you will promptly complete, sign
and return the JANA Questionnaire, (ii) your responses in the JANA
Questionnaire will be, to the best of your knowledge, true,
complete and correct in all respects, and (iii) you will provide
any additional information as may be reasonably requested by JANA.
In addition, you agree that upon our request you will execute and
return a separate instrument confirming that you consent to being
nominated for election as a director of MRCY and, if elected,
consent to serving as a director of MRCY. Upon being notified that
you have been chosen, we and the Nominating Party may forward your
consent and completed JANA Questionnaire (or summary thereof), to
MRCY, and we and the Nominating Party may at any time, in our and
their discretion, disclose the information contained therein, as
well as the existence and contents of this Agreement. Furthermore,
you understand that we may elect, at our expense, to conduct a
background and reference check on you and you agree to complete and
execute any necessary authorization forms or other documents
required in connection therewith.
You further agree that (i) you will treat confidentially all
information relating to the Proxy Solicitation which is non-public,
confidential or proprietary in nature; (ii) you will not issue,
publish or otherwise make any public statement or any other form of
communication relating to MRCY or the Proxy Solicitation without
the prior approval of JANA; and (iii) you will not agree to serve,
or agree to be nominated to stand for election by MRCY or any other
stockholder of MRCY (other than JANA), as a director of MRCY
without the prior approval of JANA.
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
15
of 17 Pages |
In addition to the purchases of Shares required by the second
paragraph above, you or your affiliates may invest in securities of
MRCY. With respect to any such purchases during the term of this
Agreement, (i) you agree to consult with JANA and provide necessary
information so that we may comply with any applicable disclosure or
other obligations which may result from such investment and (ii)
JANA or its affiliates shall prepare and complete any required
disclosures including all regulatory filings related thereto. With
respect to any such purchases made pursuant to this paragraph you
agree on behalf of yourself and your affiliates not to dispose of
any such securities prior to the termination of this Agreement.
Each of us recognizes that should you be elected or appointed to
the Board of Directors of MRCY all of your activities and decisions
as a director will be governed by applicable law and subject to
your fiduciary duties, as applicable, to MRCY and to the
stockholders of MRCY and, as a result, that there is, and can be,
no agreement between you and JANA that governs the decisions which
you will make as a director of MRCY.
This Agreement shall automatically terminate on the earliest to
occur of (i) the conclusion of the Annual Meeting, (ii) your
election or appointment to the Board of Directors of MRCY or (iii)
the termination of the Proxy Solicitation, provided, however, that
the first, second, third, your confidentiality obligations in the
sixth, eighth, and tenth paragraphs of this Agreement shall survive
such termination.
This Agreement sets forth the entire agreement between JANA and you
as to the subject matter contained herein, and cannot be amended,
modified or terminated except by a writing executed by JANA and
you. Any prior agreements with respect to this subject matter are
hereby terminated. This Agreement shall be governed by and
construed in accordance with the laws of the State of New York,
without giving effect to principles of conflicts of law.
[Signature Page Follows]
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
16
of 17 Pages |
Agreed to as of the date both parties have signed:
JANA SPECIAL
SITUATIONS MANAGEMENT, LP |
|
|
|
|
|
By: |
|
|
Name: |
|
|
Title: |
|
|
Date: |
|
|
|
|
|
|
|
|
[NAME] |
|
|
|
|
|
|
|
|
Date: |
|
|
|
|
|
|
CUSIP No. 89469A104 |
SCHEDULE 13D |
Page
17
of 17 Pages |
EXHIBIT C
Joint Filing Agreement, dated December 23, 2021
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement
on Schedule 13D is filed on behalf of each of the undersigned and
that all subsequent amendments to this statement on Schedule 13D
may be filed on behalf of each of the undersigned without the
necessity of filing additional joint filing agreements. The
undersigned acknowledge that each shall be responsible for the
timely filing of such amendments, and for the completeness and
accuracy of the information concerning him, her or it contained
herein and therein, but shall not be responsible for the
completeness and accuracy of the information concerning the others,
except to the extent that he, she or it knows that such information
is inaccurate.
Dated: December 23,
2021
|
JANA PARTNERS
LLC |
|
|
|
|
|
By: |
/s/ Jennifer
Fanjiang |
|
Name: |
Jennifer Fanjiang |
|
Title: |
Partner, Chief Legal Officer
and Chief Compliance Officer |
|
|
|
|
|
|
|
|
/s/ Jim Albaugh |
|
|
JIM ALBAUGH |
|
|
|
|
|
|
|
|
|
|
|
/s/ Bill Ballhaus |
|
|
BILL BALLHAUS |
|
|
|
|
|
|
|
|
|
|
|
/s/ Carol Lowe |
|
|
CAROL LOWE |
Mercury Systems (NASDAQ:MRCY)
Historical Stock Chart
From Apr 2022 to May 2022
Mercury Systems (NASDAQ:MRCY)
Historical Stock Chart
From May 2021 to May 2022